This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Spotlight on Inventor Michael Wichroski: Innovating in the Pharmaceutical Field
Introduction: Meet Michael Wichroski, a talented inventor based in Yardley, PA, who has made significant contributions in the pharmaceutical field. With two patents under his belt, Michael is a pioneering figure in the realm of Mer-Ax1 inhibitors and T cell activators.
Latest Patents:
1. Uracil derivatives as Mer-AXL inhibitors: Michael's invention focuses on compounds that act as Mer-Ax1 inhibitors, with applications in treating proliferative disorders such as cancer. This patent introduces novel pharmaceutical compositions and treatment methods for disorders involving dysregulated apoptosis.
2. Naphthyridinone compounds useful as T cell activators: In his second patent, Michael discloses compounds designed to inhibit the activity of diacylglycerol kinase alpha and diacylglycerol kinase zeta. These compounds have shown promise in combating viral infections and proliferative disorders like cancer.
Career Highlights: Michael Wichroski is associated with Bristol-Myers Squibb Company, a renowned pharmaceutical entity known for its groundbreaking research and development. His innovative spirit and dedication to advancing medical science have placed him at the forefront of drug discovery.
Collaborations: Throughout his career, Michael has had the privilege of working alongside esteemed colleagues such as Louis Stanley Chupak and Min Ding. Together, they have synergized their expertise to drive forward cutting-edge research initiatives and propel the boundaries of pharmaceutical innovation.
Conclusion: In conclusion, Michael Wichroski stands as a trailblazer in the pharmaceutical landscape, with his patents paving the way for novel treatment modalities in cancer and viral infections. His collaboration with industry leaders and his affiliation with Bristol-Myers Squibb Company underscore his commitment to transforming healthcare through innovative inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile